Helene Peyriere

Summary

Country: France

Publications

  1. doi request reprint Antihypertensive drugs in patients treated with antiretrovirals
    Helene Peyriere
    Medical Pharmacology and Toxicology Department, UMI233 TransVIHMI, University Hospital of Montpellier, Montpellier, France
    Ann Pharmacother 46:703-9. 2012
  2. ncbi request reprint Neurotoxicity related to valganciclovir in a child with impaired renal function: usefulness of therapeutic drug monitoring
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 40:143-6. 2006
  3. ncbi request reprint Reasons for early abacavir discontinuation in HIV-infected patients
    Helene Peyriere
    Pharmacovigilance Center, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 37:1392-7. 2003
  4. ncbi request reprint Optimal management of methotrexate intoxication in a child with osteosarcoma
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 38:422-7. 2004
  5. doi request reprint Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database
    Helene Peyriere
    Medical Pharmacology and Toxicology Department, Lapeyronie Hospital, CHU Montpellier, France
    Pharmacoepidemiol Drug Saf 18:948-55. 2009
  6. ncbi request reprint Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?
    H Peyriere
    Department of Medical Pharmacology, University Hospital of Montpellier, Hopital Lapeyronie, 971 avenue du doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
    Br J Dermatol 155:422-8. 2006
  7. ncbi request reprint [Assessment of renal abnormalities in 107 HIV patients treated with tenofovir]
    Pierre Lochet
    Service des Maladies Infectieuses et Tropicales, Hopital Gui de Chauliac, CHU Montpellier, Montpellier, France
    Therapie 60:175-81. 2005
  8. ncbi request reprint Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database
    Céline Eiden
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 41:755-63. 2007
  9. doi request reprint Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2
    Jacques Reynes
    Department of Infectious Diseases, Montpellier University Hospital, Montpellier, France
    AIDS 27:1295-302. 2013
  10. doi request reprint Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring
    Céline Eiden
    Departement of Medical Pharmacology and Toxicology, Lapeyronie Hospital, University of Montpellier I, Montpellier, France
    Xenobiotica 40:701-6. 2010

Collaborators

Detail Information

Publications30

  1. doi request reprint Antihypertensive drugs in patients treated with antiretrovirals
    Helene Peyriere
    Medical Pharmacology and Toxicology Department, UMI233 TransVIHMI, University Hospital of Montpellier, Montpellier, France
    Ann Pharmacother 46:703-9. 2012
    ....
  2. ncbi request reprint Neurotoxicity related to valganciclovir in a child with impaired renal function: usefulness of therapeutic drug monitoring
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 40:143-6. 2006
    ..To report a case of neurotoxicity related to antiviral drugs, discuss the involvement of concomitant medications, and document the pharmacokinetics of ganciclovir (administered as valganciclovir) in a child with impaired renal function...
  3. ncbi request reprint Reasons for early abacavir discontinuation in HIV-infected patients
    Helene Peyriere
    Pharmacovigilance Center, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 37:1392-7. 2003
    ..To determine incidence of and reasons for discontinuation of abacavir within the first 6 months of therapy...
  4. ncbi request reprint Optimal management of methotrexate intoxication in a child with osteosarcoma
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 38:422-7. 2004
    ..To describe the time course and management of methotrexate (MTX) toxicity in a 14-year-old Hispanic boy with osteosarcoma treated with high-dose MTX...
  5. doi request reprint Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database
    Helene Peyriere
    Medical Pharmacology and Toxicology Department, Lapeyronie Hospital, CHU Montpellier, France
    Pharmacoepidemiol Drug Saf 18:948-55. 2009
    ..First- and second-generation antipsychotics commonly cause mild gastrointestinal hypomotility. Intestinal necrosis may be a consequence of such gastrointestinal perturbations...
  6. ncbi request reprint Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?
    H Peyriere
    Department of Medical Pharmacology, University Hospital of Montpellier, Hopital Lapeyronie, 971 avenue du doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
    Br J Dermatol 155:422-8. 2006
    ....
  7. ncbi request reprint [Assessment of renal abnormalities in 107 HIV patients treated with tenofovir]
    Pierre Lochet
    Service des Maladies Infectieuses et Tropicales, Hopital Gui de Chauliac, CHU Montpellier, Montpellier, France
    Therapie 60:175-81. 2005
    ..The objectives of our study were to assess frequency, severity and outcome of renal abnormalities, as well as to determine the risk of developing hypophosphataemia in HIV-infected patients receiving tenofovir...
  8. ncbi request reprint Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database
    Céline Eiden
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 41:755-63. 2007
    ..skin rashes (17.3%), and elevations in hepatic enzymes level (approximately 10% of pts.; varying with enzymes). However, postmarketing data concerning safety of voriconazole are limited...
  9. doi request reprint Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2
    Jacques Reynes
    Department of Infectious Diseases, Montpellier University Hospital, Montpellier, France
    AIDS 27:1295-302. 2013
    ..To assess the frequency of glomerular and tubular proteinuria in a cohort of HIV-infected patients, and to determine the factors associated with each type of injury...
  10. doi request reprint Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring
    Céline Eiden
    Departement of Medical Pharmacology and Toxicology, Lapeyronie Hospital, University of Montpellier I, Montpellier, France
    Xenobiotica 40:701-6. 2010
    ..In addition, measurement of MVRC in unstable patients could quickly detect patients with impaired metabolism, in cases of subtherapeutic (C(min) <1 mg/l) or toxic (C(min) >5 mg/l) VRC plasma levels...
  11. doi request reprint Posaconazole-increased vincristine neurotoxicity in a child: a case report
    Céline Eiden
    Department of Medical Pharmacology and Toxicology, Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France
    J Pediatr Hematol Oncol 31:292-5. 2009
    ..Clinicians should be made aware of this possible drug-drug interaction...
  12. doi request reprint Toxicity and death following recreational use of 2-pyrrolidino valerophenone
    Céline Eiden
    Département de Pharmacologie Médicale et Toxicologie, Centre d Evaluation et d Information sur la Pharmacodépendance Addictovigilance, Centre Hospitalier Universitaire Montpellier, Montpellier, France
    Clin Toxicol (Phila) 51:899-903. 2013
    ..We present, here, the first documented cases of recreational use of 2-pyrrolidino valerophenone (PVP) associated with death for one patient, with post-mortem toxicological analysis...
  13. ncbi request reprint Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma
    Hélène Breton
    INSERM U 454, Arnaud de Villeneuve Hospital, Montpellier, France
    J Chromatogr B Analyt Technol Biomed Life Sci 828:80-90. 2005
    ..Precision ranged from 2 to 13% and accuracy was between 86 and 112%. This method was found suitable for the analysis of plasma samples collected during therapeutic drug monitoring of patients treated with CBZ or OXCBZ...
  14. doi request reprint Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoring
    Céline Eiden
    Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, France
    Ann Pharmacother 47:1721-6. 2013
    ..Rare cases of acute hepatitis have been reported following injection, overdose, and even during the use of buprenorphine (BPN) at therapeutic doses, especially in carriers of hepatitis C virus (HCV)...
  15. ncbi request reprint Adverse drug events associated with hospital admission
    Helene Peyriere
    Clinical Pharmacy, Laboratory of Clinical Pharmacy, College of Pharmacy, University of Montpellier, Montpellier, France
    Ann Pharmacother 37:5-11. 2003
    ..To increase the knowledge base on the frequency, causality, and avoidability of adverse drug events (ADEs) as a cause for admission in internal medicine or when occurring during hospitalization...
  16. doi request reprint New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability
    Céline Eiden
    Centre d Evaluation et d Information sur la Pharmacodépendance Addictovigilance, Centre Hospitalier Universitaire, Montpellier, France
    Therapie 68:107-11. 2013
    ..A new formulation of methadone as capsules is marketed in France since 2008. Few data are available on the patient acceptability and the risk of misuse of this new formulation...
  17. doi request reprint Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal
    Céline Eiden
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    J Addict Med 5:302-3. 2011
    ..So, it seems important to rapidly detect drugs taken by patients with mental agitation, to optimize management and minimize complications related to drugs...
  18. ncbi request reprint A case of drug-facilitated sexual assault involving 3,4-methylenedioxy-methylamphetamine
    Céline Eiden
    Centre for Evaluation and Information on Pharmacodependence, Addictovigilance, Medical Pharmacology and Toxicology Department, University Hospital of Montpellier, France
    J Psychoactive Drugs 45:94-7. 2013
    ..In the literature review, a few cases of sexual assault involving involuntarily MDMA intake are described...
  19. doi request reprint Methadone-related deaths in Montpellier and Region, from 2000 to 2010
    Céline Eiden
    Département de Pharmacologie Médicale et Toxicologie, Hopital Lapeyronie, CHU Montpellier, Montpellier, France
    Therapie 67:515-22. 2012
    ....
  20. doi request reprint Slow-release oral morphine sulfate abuse: results of the postmarketing surveillance systems for psychoactive prescription drug abuse in france
    Helene Peyriere
    Département de Pharmacologie Médicale et Toxicologie, Centre d Evaluation et d Information sur la Pharmacodépendance Addictovigilance CEIP A, Hopital Lapeyronie, Centre Hospitalier Universitaire Montpellier, Montpellier, France
    Eur Addict Res 19:235-44. 2013
    ..In France, morphine sulfate abuse is currently investigated by the health authorities. The aim of our study was to provide data on morphine sulfate abuse in France, collected during the period 1996-2011...
  21. doi request reprint [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients]
    Céline Eiden
    Service de Pharmacologie Médicale et Toxicologie, Centre d Addictovigilance, Hopital Lapeyronie, CHU Montpellier, UM1, Montpellier, France
    Therapie 67:223-30. 2012
    ..Recent studies show that high-dose methadone (>100 mg/d) allow a better control of the consumptions of illicit opiates by treated patients...
  22. ncbi request reprint [Drug-induced movement disorders: tardive syndromes]
    Jean Pierre Blayac
    Service de Pharmacologie Médicale et Toxicologie, Hopital Lapeyronie, CHU de Montpellier, 34295 Montpellier, France
    Therapie 59:113-9. 2004
    ..The current state of knowledge on this topic is summarised in this article. Clinical aspects (tardive dyskinesia, tardive dystonia and other forms), prevalence, risk factors, prevention and management are discussed...
  23. ncbi request reprint Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases
    Helene Peyriere
    Department of Medical Pharmacology, Lapeyronie Hospital, CHU Montpellier, France
    J Acquir Immune Defic Syndr 35:269-73. 2004
    ..In patients with low weight or mild preexisting renal impairment, regular monitoring of tubulopathy markers could lead to early detection of this dysfunction...
  24. ncbi request reprint Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease
    Alain Makinson
    Infectious Diseases Department, Gui de Chauliac Hospital, CHU Montpellier, France
    Eur J Haematol 78:358-60. 2007
    ..This unrecorded strategy is discussed...
  25. ncbi request reprint Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels
    Stephanie Badiou
    Laboratoire de Biochimie, Hopital Lapeyronie, Montpellier Cedex 5, France
    Eur J Clin Pharmacol 64:83-7. 2008
    ..The aim of our study was to investigate the effects of carbamazepine (CBZ) and oxcarbazepine (OXCBZ) on aminothiol levels, including homocysteine (Hcy), cysteine, and cysteinylglycine, in chronically treated patients...
  26. doi request reprint [Opioid therapy for chronic noncancer pain: retrospective analysis of patients hospitalized for withdrawal]
    Delinger Faure
    Département de Pharmacologie Médicale et Toxicologie, Centre d Addictovigilance, Hopital Lapeyronie, CHRU Montpellier, UM1, Montpellier, France
    Therapie 68:385-92. 2013
    ..In this study, 57% of patients received, at admission to hospital, an opioid other than morphine in the treatment of CNCP. The management of pain offered by the pain clinic led to a total or partial opioid withdrawal in 94% of patients. ..
  27. doi request reprint Necrosis of the intranasal structures and soft palate as a result of heroin snorting: a case series
    Helene Peyriere
    a Département de Pharmacologie Médicale et Toxicologie, Centre d Addictovigilance, Centre Hospitalier Universitaire, Montpellier, France
    Subst Abus 34:409-14. 2013
    ..The authors report here the retrospective analysis of 24 cases of orofacial lesions in patients with nasal heroin usage, collected between 2006 and 2012...
  28. doi request reprint Misuse of anabolic products in sport: a retrospective study of phone calls at the Écoute Dopage anti-doping hot-line
    Nicolas Palmié
    Centre d Addictovigilance, Département de Pharmacologie Médicale et Toxicologie, Hopital Lapeyronie, CHU Montpellier, UM1, Montpellier, France
    Therapie 68:27-9. 2013
    ..The aim of this retrospective study was to analyze the calls concerning anabolic products (AP), received at Écoute Dopage, a French anti-doping hot-line...
  29. doi request reprint Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis
    Helene Peyriere
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    Ann Pharmacother 43:973-7. 2009
    ..To report 2 cases of acute hepatitis related to intravenous administration of buprenorphine in hepatitis C-infected patients...
  30. doi request reprint [Assessment of inappropriate prescriptions in psychiatric in-patients]
    Benjamin Bord
    Service de Pharmacie, Hopital Lapeyronie, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, Montpellier, France
    Therapie 64:313-9. 2009
    ..To evaluate occurrence of the inappropriate prescriptions in a psychiatric department...